Triptorelin: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Triptorelin. Educational only — not medical advice.

Labeled uses

TRIPTODUR is indicated for the treatment of pediatric patients 2 years of age and older with central precocious puberty (CPP).

Source: FDA labeling via NIH DailyMed (set f41380e7…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.